Analysis of Regulatory Networks and Spatial Models Uncovers Mechanisms of Immune Evasion and Resistance in Estrogen Receptor-Positive Breast Cancer - Takeaways - MDSpire

Analysis of Regulatory Networks and Spatial Models Uncovers Mechanisms of Immune Evasion and Resistance in Estrogen Receptor-Positive Breast Cancer

  • By

  • Yijia Fan

  • Sarthak Sahoo

  • Mohit Kumar Jolly

  • Jason T. George

  • February 23, 2026

  • 0 min

Share

  • 1

    Estrogen receptor-positive breast cancer accounts for approximately 80% of cases and faces significant treatment resistance challenges.

  • 2

    Resistance mechanisms include genetic alterations and acquired adaptations, such as epithelial-to-mesenchymal transition and immune evasion.

  • 3

    An integrated Gene Regulatory Network revealed interactions between EMT, endocrine treatment resistance, and PD-L1 expression.

  • 4

    Reversing EMT through mesenchymal-to-epithelial transition may offer a promising therapeutic strategy for improving patient outcomes.

  • 5

    The study combines regulatory modeling and patient data to identify strategies that enhance therapeutic sensitivity in resistant tumors.

Original Source(s)

Analysis of Regulatory Networks and Spatial Models Uncovers Mechanisms of Immune Evasion and Resistance in Estrogen Receptor-Positive Breast Cancer

  • by Yijia Fan, Sarthak Sahoo, Mohit Kumar Jolly, Jason T. George

  • February 23, 2026

Related Content

This Week’s Biopharma News: New Approvals, Appeals, and AI

Datroway and Hepcludex secure notable FDA approvals, while Outlook wins its bevacizumab appeal, BioMarin reports phase 3 VOXZOGO data, and BMS partners with Anthropic

  • June 2, 2026

  • 5 min
Insulin-like growth factor 1 receptor regulates breast cancer cell adhesion through beta-1 integrin

Glandular tissue–based versus anatomical landmark–based CTV delineation in postoperative breast cancer radiotherapy: a dosimetric comparison